Alkermes, Janssen Enter Arbitration Over NanoCrystal Tech

Biopharmaceutical company Alkermes PLC said it has entered binding arbitration with Johnson & Johnson subsidiary Janssen Pharmaceutica NV over two licensing agreements for small particle pharmaceutical compound technology Janssen uses in...

Already a subscriber? Click here to view full article